SG11202010220QA - Gabaa positive allosteric modulator compounds, methods of making, and uses thereof - Google Patents
Gabaa positive allosteric modulator compounds, methods of making, and uses thereofInfo
- Publication number
- SG11202010220QA SG11202010220QA SG11202010220QA SG11202010220QA SG11202010220QA SG 11202010220Q A SG11202010220Q A SG 11202010220QA SG 11202010220Q A SG11202010220Q A SG 11202010220QA SG 11202010220Q A SG11202010220Q A SG 11202010220QA SG 11202010220Q A SG11202010220Q A SG 11202010220QA
- Authority
- SG
- Singapore
- Prior art keywords
- making
- methods
- positive allosteric
- allosteric modulator
- modulator compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862659226P | 2018-04-18 | 2018-04-18 | |
| PCT/US2019/027880 WO2019204446A1 (en) | 2018-04-18 | 2019-04-17 | Gabaa positive allosteric modulator compounds, methods of making, and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202010220QA true SG11202010220QA (en) | 2020-11-27 |
Family
ID=68239798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202010220QA SG11202010220QA (en) | 2018-04-18 | 2019-04-17 | Gabaa positive allosteric modulator compounds, methods of making, and uses thereof |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11542263B2 (ja) |
| EP (1) | EP3781566A4 (ja) |
| JP (2) | JP7449272B2 (ja) |
| KR (1) | KR20210011921A (ja) |
| CN (1) | CN112384513A (ja) |
| AU (1) | AU2019255282A1 (ja) |
| BR (1) | BR112020021104A2 (ja) |
| CA (1) | CA3096890A1 (ja) |
| CL (1) | CL2020002663A1 (ja) |
| IL (1) | IL278067A (ja) |
| MX (1) | MX2020010878A (ja) |
| SG (1) | SG11202010220QA (ja) |
| TW (1) | TW202012402A (ja) |
| WO (1) | WO2019204446A1 (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3781566A4 (en) * | 2018-04-18 | 2022-06-22 | Neurocycle Therapeutics, Inc. | GABAA-POSITIVE ALLOSTERIC MODULATING COMPOUNDS, METHODS OF PRODUCTION AND USES THEREOF |
| US20220152037A1 (en) * | 2019-03-18 | 2022-05-19 | Neurocycle Therapeutic, Inc. | Use of gabaa receptor modulators for treatment of pain |
| CN114981266A (zh) * | 2019-10-22 | 2022-08-30 | 纽罗塞克医疗公司 | Gabaa正向变构调节剂化合物、其制备方法和用途 |
| WO2021081357A1 (en) * | 2019-10-23 | 2021-04-29 | Neurocycle Therapeutics, Inc. | Treatment of epileptic conditions with gabaa receptor modulators |
| US20210401849A1 (en) * | 2020-06-30 | 2021-12-30 | University Of Mississippi Medical Center | Methods for treating benzodiazepine misuse/use disorder |
| WO2024076999A2 (en) * | 2022-10-04 | 2024-04-11 | Engrail Therapeutics, Inc. | Gabaa receptor modulators and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9813576D0 (en) * | 1998-06-24 | 1998-08-19 | Merck Sharp & Dohme | Therapeutic agents |
| AU1253002A (en) * | 2000-11-10 | 2002-05-21 | Merck Sharp & Dohme | Imidazo-triazine derivatives as ligands for gaba receptors |
| GB0117277D0 (en) | 2001-07-16 | 2001-09-05 | Merck Sharp & Dohme | Therapeutic agents |
| TWI248936B (en) | 2001-03-21 | 2006-02-11 | Merck Sharp & Dohme | Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| KR101706784B1 (ko) | 2008-05-21 | 2017-02-14 | 인사이트 홀딩스 코포레이션 | 2－플루오로－Ｎ－메틸－４－[7－（퀴놀린－6－일－메틸)－이미다조[1,2-ｂ][１,２,４]트리아진－２－일]벤즈아미드의 염 및 이의 제조 방법 |
| EP2456311A4 (en) | 2009-07-24 | 2013-01-23 | Concert Pharmaceuticals Inc | SUBSTITUTED IMIDASOTRIAZINES |
| CA3222584A1 (en) * | 2016-01-27 | 2017-08-03 | Universitat Zurich | Use of gabaa receptor modulators for treatment of itch |
| EP3781566A4 (en) * | 2018-04-18 | 2022-06-22 | Neurocycle Therapeutics, Inc. | GABAA-POSITIVE ALLOSTERIC MODULATING COMPOUNDS, METHODS OF PRODUCTION AND USES THEREOF |
-
2019
- 2019-04-17 EP EP19788410.9A patent/EP3781566A4/en active Pending
- 2019-04-17 TW TW108113441A patent/TW202012402A/zh unknown
- 2019-04-17 BR BR112020021104-4A patent/BR112020021104A2/pt unknown
- 2019-04-17 CN CN201980041321.7A patent/CN112384513A/zh active Pending
- 2019-04-17 SG SG11202010220QA patent/SG11202010220QA/en unknown
- 2019-04-17 MX MX2020010878A patent/MX2020010878A/es unknown
- 2019-04-17 WO PCT/US2019/027880 patent/WO2019204446A1/en active Application Filing
- 2019-04-17 KR KR1020207033073A patent/KR20210011921A/ko unknown
- 2019-04-17 AU AU2019255282A patent/AU2019255282A1/en active Pending
- 2019-04-17 JP JP2021506619A patent/JP7449272B2/ja active Active
- 2019-04-17 CA CA3096890A patent/CA3096890A1/en active Pending
-
2020
- 2020-10-15 CL CL2020002663A patent/CL2020002663A1/es unknown
- 2020-10-15 IL IL278067A patent/IL278067A/en unknown
- 2020-10-16 US US17/072,282 patent/US11542263B2/en active Active
-
2022
- 2022-12-28 US US18/089,661 patent/US20230139418A1/en active Pending
-
2024
- 2024-02-29 JP JP2024030150A patent/JP2024063136A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN112384513A (zh) | 2021-02-19 |
| WO2019204446A1 (en) | 2019-10-24 |
| MX2020010878A (es) | 2021-01-29 |
| JP7449272B2 (ja) | 2024-03-13 |
| CL2020002663A1 (es) | 2021-06-11 |
| CA3096890A1 (en) | 2019-10-24 |
| US20210040103A1 (en) | 2021-02-11 |
| JP2024063136A (ja) | 2024-05-10 |
| US20230139418A1 (en) | 2023-05-04 |
| AU2019255282A1 (en) | 2020-11-05 |
| TW202012402A (zh) | 2020-04-01 |
| EP3781566A4 (en) | 2022-06-22 |
| JP2021522330A (ja) | 2021-08-30 |
| BR112020021104A2 (pt) | 2021-02-23 |
| US11542263B2 (en) | 2023-01-03 |
| KR20210011921A (ko) | 2021-02-02 |
| IL278067A (en) | 2020-11-30 |
| EP3781566A1 (en) | 2021-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL278067A (en) | GABAA positive allosteric modulator compounds, methods of preparation and uses thereof | |
| IL274570A (en) | STING-modulating compounds, and methods for their preparation and use | |
| EP3674984C0 (en) | SET OF NEURAL NETWORKS | |
| EP3463355A4 (en) | DUX4 MODULATORS FOR REGULATING MUSCLE FUNCTION | |
| IL268731A (en) | New uses of anti-SIRPG antibodies | |
| IL281492A (en) | Modulators of PNPLA3 expression | |
| IL283672A (en) | trex1 modulators | |
| IL283967A (en) | Modulators of hsd17b13 expression | |
| EP3609500A4 (en) | ADIPOCYTE TREATMENT | |
| IL304618A (en) | Modulators of pcsk9 expression | |
| GB201806072D0 (en) | Methods of manufacture | |
| EP3894768C0 (en) | METHOD FOR CRYOHARDENING | |
| EP3427163A4 (en) | ANALYSIS OF DYNAMIC NETWORKS CENTERED ON NODES | |
| EP3723874A4 (en) | Dumbbell set | |
| DK3327969T3 (da) | Ny fremgangsmåde til trådløs overførsel af digital lyd | |
| SG11202102675PA (en) | Production of cellular spheroids | |
| GB201805904D0 (en) | Methods of Manufacture | |
| IL277847A (en) | Modulators of EZH2 expression | |
| HK1226397A1 (zh) | 離子通道調節劑的固體形式 | |
| EP3368693A4 (en) | OXYNTOMODULINE ANALOGUES AND METHODS OF PREPARATION AND USE | |
| IL276107A (en) | Crystalline forms of psoorstam | |
| SG11202105136WA (en) | Application of chidamide | |
| EP3843630A4 (en) | ANALYSIS OF SYMMETRY OF LIMB FUNCTION | |
| EP4048672A4 (en) | GABAA-POSITIVE ALLOSTERIC MODULATORY COMPOUNDS, METHODS OF PRODUCTION AND USES THEREOF | |
| EP3300550A4 (en) | Determination of feedback timing |